The estimated Net Worth of Gregory A Gould is at least $3.02 Milione dollars as of 27 February 2017. Mr. Gould owns over 66,666 units of NewAge Inc stock worth over $31,812 and over the last 19 years he sold NBEV stock worth over $0. In addition, he makes $2,983,650 as Chief Financial Officer at NewAge Inc.
Sign up
Mr. Gould NBEV stock SEC Form 4 insiders trading
Gregory has made over 2 trades of the NewAge Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 66,666 units of NBEV stock worth $50,000 on 27 February 2017.
The largest trade he's ever made was exercising 66,666 units of NewAge Inc stock on 27 February 2017 worth over $50,000. On average, Gregory trades about 8,333 units every 7 days since 2005. As of 27 February 2017 he still owns at least 340,231 units of NewAge Inc stock.
You can see the complete history of Mr. Gould stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gregory Gould biography
Gregory A. Gould CPA serves as Chief Financial Officer of the Company. Mr. Gould served as Chief Financial Officer of Therapure—Products (Evolve Biologics), a subsidiary of Therapure BioPharma, Inc., from November 2017 until October 2018. Mr. Gould also served as Chief Financial Officer, Treasurer and Secretary of Aytu BioScience, Inc., or Aytu (NASDAQ: AYTU), from April 2015 until November 2017, and he was the Chief Financial Officer, Secretary and Treasurer of Ampio Pharmaceuticals, Inc., or Ampio (NASDAQ: AMPE), from June 2014 until June 2017. He has held CFO and Principal Accounting Officer roles at several publicly traded corporations and has served as an independent board member and accounting expert. He is a highly accomplished financial executive with expertise in the life sciences industry. Mr. Gould is a CPA in the state of Colorado. He holds a Bachelor of Science in Business Administration from the University of Colorado, Boulder.
What is the salary of Gregory Gould?
As the Chief Financial Officer of NewAge Inc, the total compensation of Gregory Gould at NewAge Inc is $2,983,650. There are no executives at NewAge Inc getting paid more.
How old is Gregory Gould?
Gregory Gould is 53, he's been the Chief Financial Officer of NewAge Inc since 2018. There are 9 older and 4 younger executives at NewAge Inc. The oldest executive at NewAge Inc is Timothy Haas, 73, who is the Independent Director.
What's Gregory Gould's mailing address?
Gregory's mailing address filed with the SEC is C/O NEWAGE, INC., 2420 17TH STREET, SUITE 220, DENVER,, CO, 80202.
Insiders trading at NewAge Inc
Over the last 8 years, insiders at NewAge Inc have traded over $5,766,131 worth of NewAge Inc stock and bought 2,481,821 units worth $3,914,047 . The most active insiders traders include Ed Brennan, Brent D Willis e Timothy J Haas. On average, NewAge Inc executives and independent directors trade stock every 70 days with the average trade being worth of $13,942. The most recent stock trade was executed by Ed Brennan on 18 November 2021, trading 500,000 units of NBEV stock currently worth $610,000.
What does NewAge Inc's logo look like?
Complete history of Mr. Gould stock trades at NewAge Inc, Ampio Pharmaceuticals Inc e Aytu BioPharma Inc
NewAge Inc executives and stock owners
NewAge Inc executives and other stock owners filed with the SEC include:
-
Gregory Gould,
Chief Financial Officer -
Brent Willis,
Chief Executive Officer, Director -
Brent David Willis,
CEO & Director -
Gregory Fea,
Independent Chairman of the Board -
Randall Smith,
President - Morinda Holdings, Inc -
Amy Kuzdowicz,
Independent Director -
Timothy Haas,
Independent Director -
Ed Brennan,
Independent Director -
Frederick Cooper,
Director -
John Mills,
Investor Relation Officer -
Alicia Syrett,
Independent Director -
Julie Garlikov,
Chief Marketing Officer -
Kelly Olsen,
Chief Commercial Officer -
Jay Barrow,
Head of Brand -
Carin Casso Reinhardt,
Chief People Officer -
Karima McDaniel,
Chief Marketing Officer -
Michael Cunningham,
Sr. VP of Sales -
Jennifer S. Grafton,
Sr. VP & Gen. Counsel -
Lisa Mueller,
VP of Investor Relations -
Kevin Manion,
Chief Financial Officer. -
Mark H. Wilson,
Group Pres -
Julie Anderson,
-
Neil Fallon,
-
Reginald Kapteyn,
Director -
David Vanderveen,
Chief Operating Officer -
Robert J. Evans,
-
Kevin Manion,
Chief Financial Officer -
Fred W Cooper,
Director